Efficacy and bleeding risk of antithrombin supplementation in septic disseminated intravascular coagulation: a secondary survey

INTRODUCTION: In a previous report, we demonstrated a favorable trend for supplementation with antithrombin (AT) concentrate at a dosage of 3,000 IU/day over 1,500 IU/day for the treatment of sepsis-associated disseminated intravascular coagulation (DIC) in patients with an AT activity of 70% or les...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Iba, Toshiaki, Saitoh, Daizoh, Wada, Hideo, Asakura, Hidesaku
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2014
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4182824/
https://ncbi.nlm.nih.gov/pubmed/25220851
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13054-014-0497-x
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky